Changes of Plasma Ghrelin Levels and Relevant Factors in Essential Hypertensive Patients

XU Zhi-wei,ZHANG Yuan-yuan,TAO Jun,WU Wei-kang,LAN Tao-hua
DOI: https://doi.org/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2011.0115
2011-01-01
Abstract:【Objective】 This study aimed to measure the changed plasma ghrelin levels and relevant factors in hypertensive people before and after blood pressure control treatment.【Methods】 Thirty-seven hypertensive patients and 41 healthy volunteers were selected.The plasma ghrelin level was determined by ELISA and its association with clinical characteristics such as blood pressure(BP) and endothelial related indices such as Hcy,ET-1,NO,and vWF were evaluated.【Results】 Plasma ghrelin levels were significantly elevated in hypertensive patients compared to healthy controls,while plasma Hcy and NO levels were not show statistic significance between two groups.After treatment on BP control for 9 months,BP,BMI,and plasma levels of blood lipid,ghrelin,ET-1,and vWF were all significantly decreased(P < 0.01) in hypertensive patients,while plasma Hcy and NO levels were not significantly changed(P > 0.05).Plasma ghrelin levels correlated positively with ET-1 levels(r = 0.37,P < 0.01),and correlated inversely with both BMI and fasting plasma glucose(r =-0.29,P < 0.01;r =-0.26,P < 0.05).In a multiple regression analysis,using ghrelin as a dependent variable,the plasma ET-1 level was significant independent variables.【Conclusions】 This study indicates the elevation of plasma ghrelin level during the pathogenesis of hypertension probably is a protective compensatory response,which can resist the increased circulating ET-1 levels.
What problem does this paper attempt to address?